在家庭临床息护理患者中的症状和药物负担
Jayne Pawasauskas, Karina Pelejo1, Gagandeep Singh2
1PANTHERx, Pittsburgh, Pennsylvania, USA.
Journal of pain & palliative care pharmacotherapy
|November 24, 2025
概括
家庭息护理 (HBPC) 患者经常面临严重的症状和药物负担. 优化症状管理和停止处方药物可以改善患者的治疗结果,减少多药.
科学领域:
- 老年病的医生 老年病的医生
- 抚慰性护理是一种缓解性护理.
- 药理学 药理学是指药理学的学科.
背景情况:
- 家庭息治疗 (HBPC) 旨在通过管理复杂的症状来提高生活质量.
- 尽管HBPC有好处,但患者经常经历持续的症状困扰和高药物负担.
研究的目的:
- 评估HBPC患者的症状患病率和严重程度.
- 在这个人群中量化药物负担和复杂性.
- 识别药物治疗抑郁症的机会,以改善患者护理.
主要方法:
- 在两年内,对109名被转诊到HBPC实践的患者进行了回顾性分析.
- 数据收集包括患者人口统计,症状报告,药物清单和表现状况.
- 分析的重点是症状负担,药物计数,复杂度得分和药物不良反应 (ADRs).
主要成果:
- 患者报告平均有4.1种症状,疼痛和抑郁是最常见的.
- 平均患者服用了11.1种药物,24%的人服用15种或更多药物.
- 近一半 (49.5%) 经历了药物不良反应 (ADRs),38.5% 有了抑郁症的机会.
结论:
- 患有HBPC的患者表现出大量的症状和药物负担,影响生活质量.
- 针对性干预症状管理和脱处方是优化护理和减少多药的关键.
- 减少药物负担可能会导致在家接受息护理的患者的健康状况改善.
相关概念视频
01:25Continuing Care
1.8K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
01:28Drug Therapy
235
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
235
01:26COPD: Management Using Bronchodilators and Corticosteroids
706
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
706
01:22Heart Failure VI: Adjunct Therapies
239
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
239
01:15Drug Dosing: Geriatric Patients
214
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
214